Disability and borderline personality symptoms.
Sansone
Randy A
RA
Hruschka
Judith
J
Vasudevan
Archana
A
Miller
Stephanie N
SN
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy*; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D008875:Middle Aged; D000078785:Mirtazapine; D016896:Treatment Outcome
D000317:Adrenergic alpha-Antagonists; D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine